Division of Danaher Corp.
Latest From Cepheid
GE is replacing John Flannery as chairman and CEO with H. Lawrence Culp, formerly the chief of Danaher. But the change in leadership will not alter the company's previously announced plan to spin off GE Healthcare as a stand-alone business and make some other structural changes, the company says.
Derived from Strategic Transactions, Informa’s premium source for tracking life-sciences deals, the bimonthly Pacts In Medtech column pulls up notable technology alliances, R&D partnerships and commercial collaborations. In this edition, we highlight industry pacts that were sealed in May and June 2017.
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in June 2017.
A year after launching its first product, rapid molecular diagnostics specialist HiberGene now has a trio of infectious diseases tests under its belt. One of the tests, designed to detect Group B Streptococcus in pregnant women, is expected to be a major cash generator for the firm once it begins its sales ramp-up.
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
Research, Analytical Equipment & Supplies
- PCR & Amplification Tools
- Therapeutic Areas
- Infectious & Viral Diseases
- North America
- Parent & Subsidiaries
- Danaher Corp.
- Senior Management
John L Bishop, CEO
Daniel E Madden, EVP, CFO
Peter Farrell, EVP, WW Commercial Ops.
David H Persing, MD, PhD, EVP, CMO & CTO
Warren Kocmond, Pres. & COO
- Contact Info
Phone: (408) 541-4191
904 Carribean Dr.
Sunnyvale, CA 94089
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.